Expert Rev Pharmacoeconomics Outcomes Res. 2010;10(3):317-328. Surgical site infections in the general population are associated with a two- to three-fold increased risk of death, and a 60% ...

A trial supported by Birmingham Clinical Trials Unit explores methods to reduce post-operative surgical site infections.

Rodman & Renshaw initiated coverage on PolyPid Ltd. (NASDAQ:PYPD), a late-stage biopharmaceutical company, with a Buy rating and a price target of $13.00. PolyPid specializes in the controlled and ...

Women report less pain after a laparoscopic procedure than the abdominal incision procedure ... sometimes given to reduce the risk of post-surgical infection. If both ovaries are removed ...

Oppenheimer 35th Annual Healthcare Life Sciences Conference PolyPid’s presentation will be available on-demand beginning on Wednesday, February 12, 2025 at 11:20 AM Eastern Time and for 365 days after ...